The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Primary age-related tauopathy (PART): a common pathology associated with human aging
Open accessAbstract
We recommend a new term, "primary age-related tauopathy" (PART), to describe a pathology that is commonly observed in the brains of aged individuals. Many autopsy studies have reported brains with neurofibrillary tangles (NFTs) that are indistinguishable from those of Alzheimer's disease (AD), in the absence of amyloid (Aβ) plaques. For these "NFT+/Aβ-" brains, for which formal criteria for AD neuropathologic changes are not met, the NFTs are mostly restricted to structures in the medial temporal lobe, basal forebrain, brainstem, and olfactory areas (bulb and cortex). Symptoms in persons with PART usually range from normal to amnestic cognitive changes, with only a minority exhibiting profound impairment. Because cognitive impairment is often mild, existing clinicopathologic designations, such as "tangle-only dementia" and "tangle-predominant senile dementia", are imprecise and not appropriate for most subjects. PART is almost universally detectable at autopsy among elderly individuals, yet this pathological process cannot be specifically identified pre-mortem at the present time. Improved biomarkers and tau imaging may enable diagnosis of PART in clinical settings in the future. Indeed, recent studies have identified a common biomarker profile consisting of temporal lobe atrophy and tauopathy without evidence of Aβ accumulation. For both researchers and clinicians, a revised nomenclature will raise awareness of this extremely common pathologic change while providing a conceptual foundation for future studies. Prior reports that have elucidated features of the pathologic entity we refer to as PART are discussed, and working neuropathological diagnostic criteria are proposed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Perivascular, subpial, and periventricular p-tau immunoreactive NFTs and astrocytic tangles in the neocortex have been reported to be characteristic of both primary age-related tauopathy (PART) [35] and age-related tau astrogliopathy (ARTAG) [36].”
From The Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features (2017) · cites this paper as [35]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Primary age-related tauopathy (PART) and aging-related tau astrogliopathy (ARTAG) are independent tau pathologies commonly observed in patients over 80 years of age, and PART may account for a proportion of the misdiagnosed clinical AD cases in the elderly [130, 141, 142].”
From The neuropathological diagnosis of Alzheimer's disease (2019) · cites this paper as [142]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lesions are found in the hippocampus and adjacent regions similar to those observed in Braak I-IV, but PART is distinct from AD in that it lacks amyloid plaques, and it has distinct morbidity and age range [130, 142].”
From The neuropathological diagnosis of Alzheimer's disease (2019) · cites this paper as [142]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“PART refers to neuronal tau pathology and ARTAG is characterized by astrocytic tau pathology, although they are not mutually exclusive, and appear to be more a manifestation of age than a subtype of neurodegenerative disease.”
From The Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features (2017) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many studies, from the histopathology of Braak and Braak4 to longitudinal studies of Tau positron emission tomography imaging27,28, demonstrate that MTG is a transition zone between aging-related or preclinical AD-related medial temporal lobe pTau and more advanced stages of AD, where neocortical pTau extends across the brain and is strongly correlated with dementia4,29–31.”
From Integrated multimodal cell atlas of Alzheimer’s disease (2024) · cites this paper as [29]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It should be noted that tau aggregation in the brain is associated with older age and is generally uncommon in healthy young adults (Braak et al., 2011; Crary et al., 2014).”
From Tauopathy and Epilepsy Comorbidities and Underlying Mechanisms (2022) · cites this paper as Crary et al., 2014
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“LATE and PART are common neuropathologies, indicating the importance of addressing potential relationships between AD-Mimics, and LATE and PART pathology in future research (20,22).”
From Concordance of Clinical Alzheimer Diagnosis and Neuropathological Features at Autopsy (2020) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“AD-Mimics and definite PART are both defined as having no neuritic plaques, and like the AD-Mimics in this study, PART participants are generally older and experience less severe cognitive dysfunction (22,23).”
From Concordance of Clinical Alzheimer Diagnosis and Neuropathological Features at Autopsy (2020) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“The compact NFTs observed are morphologically most like those seen in primary age-related tauopathy (PART) [4], Alzheimer’s disease (AD) [22], and chronic traumatic encephalopathy (CTE) [13, 14], but the topographical distribution and immunostaining characteristics differ from these more common tauopathies in several respects.”
From Tuberous sclerosis complex is associated with a novel human tauopathy (2023) · cites this paper as [4]
In the citing paper
“APOE4 significantly aggravated tau-mediated neurodegeneration in a tauopathy mouse model and induced tau aggregates in brain, while genetic ablation of APOE attenuated tau-induced neurodegeneration [469, 470].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [470]
In the citing paper
“In AD and PART, the tau aggregates are a mixture of three-repeat and four-repeat tau isoforms, whereas four-repeat sequences dominate in PSP and CBD and three-repeat sequences predominate in Pick disease14,18,19,21.”
From Tau-targeting therapies for Alzheimer disease (2018) · cites this paper as [14]
In the citing paper
“More recently, Crary et al. coined the term “primary age-related tauopathy” (PART) after observing that the postmortem brains of many elderly individuals harbor NFTs indistinguishable from those of AD but in the absence of Aβ plaques or cognitive decline [44].”
From Systems-based proteomics to resolve the biology of Alzheimer’s disease beyond amyloid and tau (2021) · cites this paper as [44]
In the citing paper
“The panel did not ultimately accept all of the a priori criteria for CTE; they did not include pathology known to be associated with aging (i.e.primary age-related tauopathy [PART] [16] and aging-related tau astrogliopathy [ARTAG] [17]).”
From Mild Chronic Traumatic Encephalopathy Neuropathology in People With No Known Participation in Contact Sports or History of Repetitive Neurotrauma (2019) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Self-citationNeuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Self-citationBraak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172
Self-citationHyman, B. T., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.10.007 · Cited by 3,092
Self-citationMontine, T. J., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., Mirra, S. S., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0910-3 · Cited by 2,894 · cited 3×
“the current guidelines for AD [64, 102], mild Aβ plaques”
BackgroundInfluentialSelf-citationConsortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G., & Heyman, A. (2002) · doi:10.1002/0470846410.ch42(iii · Cited by 2,859
Staging of alzheimer's disease-related neurofibrillary changes
Braak, H., & Braak, E. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00021-6 · Cited by 2,357
Cited by
Sorted by citations
Items 901–1,000 of 1,002
Carlos, A. F., Machulda, M. M., Rutledge, M. H., Nguyen, A. T., Reichard, R. R., Baker, M., Rademakers, R., Dickson, D. W., Petersen, R. C., & Josephs, K. A. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221094 · Cited by 11
Self-citationInsights into amyloid precursor protein target through PPI network analysis
Kumar, A. (2024) · Bioinformation · doi:10.6026/973206300200140 · Cited by 11
Towards a Biological Definition of Alzheimer Disease
Jellinger Kurt, A. (2019) · International Journal of Neurology and Neurotherapy · doi:10.23937/2378-3001/1410095 · Cited by 11
Estimation of Causal Effects in the Presence of Unobserved Confounding in the Alzheimer’s Continuum
Pölsterl, S., & Wachinger, C. (2021) · Lecture notes in computer science · doi:10.1007/978-3-030-78191-0_4 · Cited by 11
Cognitive Decline Assessment: A Review From Medical Imaging Perspective
Dartora, C. M., Borelli, W. V., Koole, M. J. B., & da Silva, A. M. M. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.704661 · Cited by 11
Havlicek, D. F., Furhang, R., Nikulina, E., Smith-Salzberg, B., Lawless, S., Severin, S., Mallaboeva, S., Nayab, F., Seifert, A. C., Crary, J. F., et al. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114241 · Cited by 11
Self-citationCantero, J. L., Atienza, M., Sánchez‐Juan, P., Rodríguez‐Rodríguez, E., Vázquez‐Higuera, J. L., Pozueta, A., González‐Suárez, A., Vilaplana, E., Pegueroles, J., Montal, V., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.12.010 · Cited by 11
Shepherd, T. M., & Nayak, G. K. (2019) · Topics in Magnetic Resonance Imaging · doi:10.1097/rmr.0000000000000225 · Cited by 11
Humphrey, W. O., Martindale, R., Pendlebury, W. W., & DeWitt, J. C. (2020) · Brain Pathology · doi:10.1111/bpa.12919 · Cited by 11
Pathobiolgy and Management of Alzheimer's Disease
Kim, H., & Chung, J. Y. (2021) · Chonnam Medical Journal · doi:10.4068/cmj.2021.57.2.108 · Cited by 11
Lost in space(s): Multimodal neuroimaging of disorientation along the Alzheimer's disease continuum
Peters‐Founshtein, G., Gazit, L., Naveh, T., Domachevsky, L., Korczyn, A. D., Bernstine, H., Shaharabani‐Gargir, L., Groshar, D., Marshall, G. A., & Arzy, S. (2024) · Human Brain Mapping · doi:10.1002/hbm.26623 · Cited by 10
Entorhinal vessel density correlates with phosphorylated tau and TDP‐43 pathology
Rodríguez, J. L., van der Kouwe, A. J. W., Oltmer, J., Rosenblum, E. W., Mercaldo, N. D., Fischl, B. R., Marshall, M., Frosch, M. P., & Augustinack, J. C. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13896 · Cited by 10
Brain aging and Alzheimer’s disease, a perspective from non-human primates
Ferrer, I. (2024) · Aging · doi:10.18632/aging.206143 · Cited by 10
Ziontz, J., Harrison, T. M., Fonseca, C. S., Giorgio, J., Han, F., Lee, J., Jagust, W. J., & Initiative, A. D. N. (2024) · Human Brain Mapping · doi:10.1002/hbm.70083 · Cited by 10
Wang, X. L., Shao, X., Yu, L., Sun, J., Yin, X., Chen, Z., Xu, Y., Wang, N., Zhang, D., Qiu, W., et al. (2025) · Molecular Brain · doi:10.1186/s13041-025-01180-3 · Cited by 10
Tau and tauopathies across primate species: implications for modeling neurodegenerative disorders
Colwell, J. C., & Emborg, M. E. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1598245 · Cited by 10
Hippocampal tau distribution in primary age‐related tauopathy: The Vantaa 85+ Study
Savola, S. E., Tuimala, J., Kivistö, V., Kero, M., Raunio, A., Kumar, D., Puttonen, H. A. J., Tynninen, O., Paetau, A. E., Polvikoski, T. M., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70613 · Cited by 10
Serum IGF-BP2 strongly moderates age's effect on cognition: a MIMIC analysis
Royall, D. R., Bishnoi, R. J., & Palmer, R. F. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.04.003 · Cited by 10
Yousefzadeh‐Nowshahr, E., Winter, G., Bohn, P., Kneer, K., Arnim, C. A. F. V., Otto, M., Solbach, C., Anderl‐Straub, S., Polivka, D., Fissler, P., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0266906 · Cited by 10
Baldeiras, I., Silva‐Spínola, A., Lima, M., Leitão, M. J., Durães, J., Vieira, D., Tábuas‐Pereira, M., Cruz, V. T., da Rocha, R. P., Alves, L., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220587 · Cited by 10
The Adult Neurogenesis Theory of Alzheimer’s Disease
Abbate, C. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221279 · Cited by 11
Tang, J., Sun, R., Wan, J., Xu, Z., Gong, Y., Zou, Y. F., & Zhang, Q. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00103 · Cited by 10
Synthesis and Bioevaluation of 2-Styrylquinoxaline Derivatives as Tau-PET Tracers
Wu, N., Zhang, L., Zhang, X., Zhang, Q., Liu, J., Li, Y., Yan, X., Liang, Y., Zhang, J., & Cui, M. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c00717 · Cited by 10
Wennström, M., Schultz, N., Gallardo, P. M., Bank, T. N. B., Serrano, G. E., Beach, T. G., Bose, S., & Hansson, O. (2024) · Cells · doi:10.3390/cells13040331 · Cited by 10
Self-citationBrain pathology and symptoms linked to concussion history: beyond chronic traumatic encephalopathy
Taskina, D., Zhu, C., Schwab, N., & Hazrati, L. (2024) · Brain Communications · doi:10.1093/braincomms/fcad314 · Cited by 10
Apolipoprotein E and Alzheimer’s disease pathology in African American older adults
Royse, S. K., Snitz, B. E., Hill, A. V., Reese, A. C., Roush, R. E., Kamboh, M. I., Bertolet, M. H., Saeed, A., Lopresti, B. J., Villemagne, V. L., et al. (2024) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2024.03.005 · Cited by 10
Alzheimer’s Disease Neuropathological Change in Aged Non-Primate Mammals
Ferrer, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158118 · Cited by 13
Zhou, Z., Wang, Q., Liu, L., Wang, Q., Zhang, X., Li, C., Liu, J., Wei, Y., Gao, J. H., Fu, L., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01690-1 · Cited by 10
Jeon, S. Y., Yi, D., Byun, M. S., Choi, H. J., Kim, H. J., Lee, J. H., Baek, H., Choe, Y. M., Lee, Y., Woo, J. I., et al. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.08.045 · Cited by 10
Jang, J., Park, J. H., Kim, S., Park, Y. H., Pyun, J., Lim, J., Kim, Y., Youn, Y. C., Kim, S., & Initiative, T. A. D. N. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201852 · Cited by 10
Shafiei, A., Haghighi, A. H., Askari, R., Keyhani, A., Nabavizadeh, M. S., & Asadi‐Shekaari, M. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00532-4 · Cited by 10
Exploring discordant low amyloid beta and high neocortical tau positron emission tomography cases
Krishnadas, N., Doré, V., Laws, S. M., Porter, T., Lamb, F., Bozinovski, S., Villemagne, V. L., & Rowe, C. C. (2022) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12326 · Cited by 10
Allegri, R., Méndez, P. C., Russo, M. J., Cohen, G., Calandri, I. L., Campos, J., Nahas, F., Surace, E. I., Vázquez, S., & Sevlever, G. E. (2018) · Neurología · doi:10.1016/j.nrl.2017.12.011 · Cited by 10
Finding New Communities: A Principle of Neuronal Network Reorganization in Alzheimer's Disease
Weller, A., Bischof, G. N., Schlüter, P., Richter, N., Dronse, J., Onur, O. A., Neumaier, B., Kukolja, J., Langen, K., Fink, G. R., et al. (2020) · Brain Connectivity · doi:10.1089/brain.2020.0889 · Cited by 10
An Overview of Transgenic Mouse Models for the Study of Alzheimer’s Disease
Lopes, P. A., Pádua, M. S., & Guil‐Guerrero, J. L. (2025) · Journal of dementia and Alzheimer's disease · doi:10.3390/jdad2010002 · Cited by 9
Ghatamaneni, S., Coleman, C., Shin, I., Bruinsma, T. J., Scott, N. E., Lee, J., Fang, P., Min, H.-K. P., Moloney, C. M., Wood, A. C., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02864-9 · Cited by 9
Self-citationZingale, G. A., Distefano, A., & Grasso, G. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230116162646 · Cited by 9
Zamorano, M., Alexander, J. F., Catania, D., Dharmaraj, S., Kavelaars, A., & Heijnen, C. J. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00328-w · Cited by 9
Tosun, D., Thropp, P., Southekal, S. S., Spottiswoode, B. S., Fahmi, R., & Initiative, A. D. N. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13164 · Cited by 9
Iverson, G. L., Jamshidi, P., Fisher‐Hubbard, A., Deep‐Soboslay, A., Hyde, T. M., Kleinman, J. E., deJong, J. L., Shepherd, C. E., Hazrati, L., & Castellani, R. J. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1143882 · Cited by 9
Liu, F., Shi, Y., Wu, Q., Chen, H., Wang, Y., Cai, L., & Zhang, N. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14418 · Cited by 9
Remote Associations Between Tau and Cortical Amyloid-β Are Stage-Dependent
Hojjati, S. H., Chiang, G. C.-Y., Butler, T., de Leon, M. J., Gupta, A. K., Li, Y., Sabuncu, M. R., Feiz, F., Nayak, S., Shteingart, J., et al. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231362 · Cited by 9
Galgani, A., Lombardo, F. P., Frijia, F., Martini, N., Tognoni, G., Pavese, N., & Giorgi, F. S. (2024) · Brain Structure and Function · doi:10.1007/s00429-024-02797-1 · Cited by 9
Saez-Calveras, N., Vaquer‐Alicea, J., White, C. L., Tak, Y., Cosentino, S., Faust, P. L., Louis, E. D., & Diamond, M. I. (2025) · Acta Neuropathologica · doi:10.1007/s00401-024-02843-6 · Cited by 9
Self-citationTraumatic Brain Injury and Alzheimer’s Disease: A Shared Neurovascular Hypothesis
Cognacq, G., Attwood, J. E., & DeLuca, G. C. (2025) · Neuroscience Insights · doi:10.1177/26331055251323292 · Cited by 9
A Naturally Occurring Bovine Tauopathy Is Geographically Widespread in the UK
Jeffrey, M., Piccardo, P., Ritchie, D. L., Ironside, J. W., Green, A. J. E., & McGovern, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129499 · Cited by 9
The complex link between amyloid and neuronal dysfunction in Alzheimer’s disease
Sorg, C., & Grothe, M. J. (2015) · Brain · doi:10.1093/brain/awv302 · Cited by 9
Robinson, A., Chew-Graham, S., Davidson, Y. S., Horan, M. A., Roncaroli, F., Minshull, J., du Plessis, D., Pal, P., Payton, A., Pendleton, N., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190580 · Cited by 9
Abbate, C., Trimarchi, P. D., Inglese, S., Gallucci, A., Tomasini, E., Bagarolo, R., & Giunco, F. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00229 · Cited by 9
Clear‐headed into old age: Resilience and resistance against brain aging—A PET imaging perspective
Hoenig, M. C., & Drzezga, A. E. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15598 · Cited by 9
Gicas, K. M., Honer, W. G., Leurgans, S. E., Wilson, R. S., Boyle, P. A., Schneider, J. A., & Bennett, D. A. (2022) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617722000595 · Cited by 9
Self-citationKim, Y. A., Mellén, M., Kızıl, Ç., & Santa‐María, I. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16280 · Cited by 9
Korde, D. S., & Humpel, C. (2024) · Biomolecules · doi:10.3390/biom14020165 · Cited by 9
Towards the virtual human patient. Quantitative Systems Pharmacology in Alzheimer's disease
Geerts, H., Spiros, Ä., Roberts, P., & Carr, R. A. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.05.062 · Cited by 9
Understanding the Relevance of Aging-Related Tau Astrogliopathy (ARTAG)
Kovács, G. G. (2018) · Neuroglia · doi:10.3390/neuroglia1020023 · Cited by 9
Robinson, A., Roncaroli, F., Chew-Graham, S., Davidson, Y. S., Minshull, J., Horan, M. A., Payton, A., Pendleton, N., & Mann, D. M. A. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200339 · Cited by 9
Adams, S. L., Benayoun, L., Tilton, K., Mellott, T. J., Seshadri, S. S., Blusztajn, J. K., & Delalle, I. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171065 · Cited by 9
Shigemoto, Y., Sone, D., Okita, K., Maikusa, N., Yamao, T., Kimura, Y., Suzuki, F., Fujii, H., Kato, K., Sato, N., et al. (2021) · eNeurologicalSci · doi:10.1016/j.ensci.2021.100309 · Cited by 9
Salloway, S., & Sperling, R. A. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.1804 · Cited by 9
Clinical Impact of Amyloid Positron Emission Tomography—Is It Worth the Cost?
Caselli, R. J., & Woodruff, B. K. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.3792 · Cited by 9
Taylor, W. D. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16111317 · Cited by 9
Walkiewicz, G., Ronisz, A., Ospitalieri, S., Tsaka, G., Tomé, S. O., Vandenberghe, R. R., Arnim, C. A. F. V., Rousseau, F., Schymkowitz, J. W. H., Groef, L. D., et al. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01907-8 · Cited by 8
Self-citationWeiner, S., Sauer, M., Montoliu‐Gaya, L., Benedet, A. L., Ashton, N. J., González‐Ortiz, F., Simrén, J., Rahmouni, N., Tissot, C., Therriault, J., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00841-0 · Cited by 8
Yang, T., Zhang, D., Huang, H., Liu, F., Wu, J., Ma, X., Liu, S., Huang, M., Zhou, Y., & Shen, Y. (2025) · Brain · doi:10.1093/brain/awaf186 · Cited by 10
Nasir, A. R., & Nouh, C. D. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1671419 · Cited by 8
Tian, Y., Gao, G., & Dai, J. (2022) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2022.102105 · Cited by 9
Neuropathologic Findings in Elderly HIV-Positive Individuals
Magaki, S., Vinters, H. V., Williams, C. K., Mareninov, S., Khanlou, N., Said, J. W., Nemanim, N. M., Gonzalez, J., Morales, J. G., Singer, E. J., et al. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlac040 · Cited by 8
The Aging Patterns of Brain Structure, Function, and Energy Metabolism
Dang, M., Sang, F., Long, S., & Chen, Y. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-1627-6_7 · Cited by 8
Interaction Between a High-Fat Diet and Tau Pathology in Mice: Implications for Alzheimer’s Disease
Jang, Y. J., Choi, M. G., Yoo, B. J., Lee, K. J., Jung, W. B., Kim, S., & Park, S. A. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230927 · Cited by 8
Barnes, C. A., Permenter, M. R., Vogt, J. A., Chen, K., & Beach, T. G. (2024) · The Journal of Comparative Neurology · doi:10.1002/cne.25670 · Cited by 8
Self-citationThientunyakit, T., Muangpaisan, W., & Minoshima, S. (2025) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2025.04.007 · Cited by 8
Kovács, G. G., Respondek, G., van Eimeren, T., Holler, E., Levin, J., Müller, U., Schwarz, S. C., Rösler, T. W., Schweyer, K., & Höglinger, G. U. (2018) · Der Nervenarzt · doi:10.1007/s00115-018-0584-3 · Cited by 8
Sporadic Creutzfeldt–Jakob disease with extremely long 14‐year survival period
Zubizarreta, I. K., Onandi, R. R., Pereda, A., Vado, Y., González‐Chinchon, G., Eraña, H., de Nanclares, G. P., & Castilla, J. (2021) · European Journal of Neurology · doi:10.1111/ene.14946 · Cited by 8
Significance of a positive tau PET scan with a negative amyloid PET scan
Robinson, C. G., Lee, J., Min, H.-K. P., Przybelski, S. A., Josephs, K. A., Jones, D. T., Graff‐Radford, J., Boeve, B. F., Knopman, D. S., Jack, C. R., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13608 · Cited by 8
Self-citationOkamoto, K., Amari, M., Fukuda, T., Suzuki, K., & Takatama, M. (2017) · Neuropathology · doi:10.1111/neup.12367 · Cited by 8
[18F]THK-5351 PET Patterns in Patients With Alzheimer’s Disease and Negative Amyloid PET Findings
Oh, M., Oh, J. S., Oh, S. J., Lee, S. J., Roh, J. H., Kim, W., Seo, H., Kang, J. M., Seo, S. W., Lee, J., et al. (2022) · Journal of Clinical Neurology · doi:10.3988/jcn.2022.18.4.437 · Cited by 8
Toniolo, S., Lorenzo, F. D., Bernardini, S., Mercuri, N. B., & Sancesario, G. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512151 · Cited by 8
Iacono, D., Geraci-Erck, M., Peng, H., & Bouffard, J. (2016) · Journal of Visualized Experiments · doi:10.3791/54602 · Cited by 8
Sporadic Creutzfeldt-Jakob Disease and Other Proteinopathies in Comorbidity
Parobková, E., van der Zee, J., Dillen, L., Broeckhoven, C. V., Rusina, R., & Matěj, R. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.596108 · Cited by 8
Hayashi, T., Shimonaka, S., Elahi, M., Matsumoto, S., Ishiguro, K., Takanashi, M., Hattori, N., & Motoi, Y. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201002 · Cited by 8
Neuropathology of the temporal lobe
Boluda, S., Seilhean, D., & Bielle, F. (2022) · Handbook of clinical neurology · doi:10.1016/b978-0-12-823493-8.00027-4 · Cited by 8
Incidental corticobasal degeneration
Martínez-Maldonado, A., Luna‐Muñoz, J., & Ferrer, I. (2016) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12339 · Cited by 8
Kim, E.-J., Vatsavayai, S., & Seeley, W. W. (2016) · The Behavioral Neurology of Dementia · doi:10.1017/9781139924771.008 · Cited by 7
Self-citationArndt, P., Pfister, M., Perosa, V., Mattern, H., Bernal, J., John, A.-C., Dörner, M., Müller, P., Braun-Dullaeus, R. C., Garz, C., et al. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13087-z · Cited by 7
Celebrating 40 years of the University of Kentucky Alzheimer's Disease Research Center
Schmitt, F. A., Abner, E. L., Fardo, D. W., Gold, B. T., Jicha, G. A., Kryscio, R. J., Lee, D. C., Nelson, P. T., & Eldik, L. J. V. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70181 · Cited by 7
Self-citationAngiotensin II–Stimulating Antihypertensive Medications and Dementia-Related Neuropathology
Gray, S. L., Yu, O., Gatto, N. M., Marcum, Z. A., Latimer, C. S., Postupna, N. O., Su, Y.-R., Barthold, D., van Dalen, J. W., Richard, E., et al. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.59113 · Cited by 7
Jellinger, K. A. (2022) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2022.105273 · Cited by 7
Self-citationChang, H., Huang, C., Huang, S., Hsu, S., Lin, K., Ho, T., Wu, H., & Chang, C. (2024) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13680 · Cited by 7
Diagnosis of Alzheimer’s Disease in Clinical Practice: Time to Incorporate Biomarkers?
Vyhnálek, M., Laczó, M., & Laczó, J. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240660 · Cited by 7
Yang, C. G., Sun, Z.-P., Jiang, J., Cai, X.-L., Wang, Y., Wang, H., Che, C., Tu, E., Pan, A., Zhang, Y., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-77026-0 · Cited by 7
Villemagne, V. L., Okamura, N., & Rowe, C. C. (2016) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.05.001 · Cited by 7
Li, J., Song, J., Suckling, J., Wang, Y., Zuo, C., Zhang, C. M., Gao, J., Song, Y., Xie, A., Tan, L., et al. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.11.002 · Cited by 7
Amyloid-β Pathology Is the Common Nominator Proteinopathy of the Primate Brain Aging
Ferrer, I. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240389 · Cited by 7
The use of amyloid imaging in clinical praxis: a critical review
Nordberg, A. K. (2015) · Clinical and Translational Imaging · doi:10.1007/s40336-015-0100-8 · Cited by 7
Postmortem imaging and neuropathologic correlations
Augustinack, J. C., & van der Kouwe, A. J. W. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53486-6.00069-7 · Cited by 7
Busatto, G. F., Porto, F. H. G., Faria, D. D. P., Squarzoni, P., Coutinho, A. M., Garcez, A. T., Rosa, P. G. P., da Costa, N. A., Carvalho, C. L., Torralbo, L., et al. (2020) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12122 · Cited by 7
Sakurai, K., Kaneda, D., Inui, S., Uchida, Y., Morimoto, S., Nihashi, T., Kato, T., Ito, K., & Hashizume, Y. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210043 · Cited by 7
Squarcio, F., Hitrec, T., Piscitiello, E., Cerri, M., Giovannini, C., Martelli, D., Occhinegro, A., Taddei, L., Tupone, D., Amici, R., et al. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1129278 · Cited by 7
Tau in dementia with Lewy bodies
Chin, K. S., Churilov, L. P., Doré, V., Villemagne, V. L., Rowe, C. C., Yassi, N., & Watson, R. (2023) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/00048674231177219 · Cited by 7
Amyloid-Tau-Neurodegeneration Profiles and Longitudinal Cognition in Sporadic Young-Onset Dementia
Vipin, A., Koh, C. L., Wong, B. Y. X., Zailan, F. Z., Tan, J. Y., Soo, S. A., Satish, V., Kumar, D., Wang, B. Z., Ng, A. S. L., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220448 · Cited by 7
Metadata
- Authors
- Crary, J. F., Trojanowski, J. Q., Schneider, J. A., Abisambra, J. F., Abner, E. L., Alafuzoff, I., Arnold, S. E., Attems, J., Beach, T. G., Bigio, E. H., Cairns, N. J., Dickson, D. W., Gearing, M., Grinberg, L. T., Hof, P. R., Hyman, B. T., Jellinger, K., Jicha, G. A., Kovacs, G. G., Knopman, D. S., Kofler, J., Kukull, W. A., Mackenzie, I. R., Masliah, E., McKee, A., Montine, T. J., Murray, M. E., Neltner, J. H., Santa-Maria, I., Seeley, W. W., Serrano-Pozo, A., Shelanski, M. L., Stein, T., Takao, M., Thal, D. R., Toledo, J. B., Troncoso, J. C., Vonsattel, J. P., White, C. L., Wisniewski, T., Woltjer, R. L., Yamada, M., & Nelson, P. T.
- Affiliations
- Columbia University Irving Medical Center (US)
- University of Pennsylvania (US)
- Rush University Medical Center (US)
- University of Kentucky (US)
- Uppsala University (SE)
- Newcastle University (GB)
- Banner Sun Health Research Institute (US)
- Northwestern University (US)
- Washington University in St. Louis (US)
- Mayo Clinic (US)
- Emory University (US)
- Universidade de São Paulo (BR)
- Icahn School of Medicine at Mount Sinai (US)
- Harvard University (US)
- University of Pittsburgh Medical Center (US)
- University of Washington (US)
- University of British Columbia (CA)
- University of California San Diego (US)
- Boston University (US)
- University of California, San Francisco (US)
- Tokyo Metropolitan Geriatric Hospital (JP)
- Universität Ulm (DE)
- The University of Texas Southwestern Medical Center (US)
- Oregon Health & Science University (US)
- Kanazawa University (JP)
- Corresponding author
- Crary, John F.
- Nelson, Peter T.
- ORCID
- Crary, John F.
- Trojanowski, John Q.
- Schneider, Julie A.
- Abisambra, Jose F.
- Abner, Erin L.
- Alafuzoff, Irina
- Arnold, Steven E.
- Attems, Johannes
- Beach, Thomas G.
- Bigio, Eileen H.
- Dickson, Dennis W.
- Gearing, Marla
- Grinberg, Lea T.
- Hof, Patrick R.
- Hyman, Bradley T.
- Jellinger, Kurt
- Jicha, Gregory A.
- Knopman, David S.
- Kofler, Julia
- Kukull, Walter A.
- Mackenzie, Ian R.
- Masliah, Eliezer
- McKee, Ann
- Montine, Thomas J.
- Murray, Melissa E.
- Neltner, Janna H.
- Seeley, William W.
- Shelanski, Michael L.
- Stein, Thor
- Takao, Masaki
- Thal, Dietmar R.
- Troncoso, Juan C.
- White, Charles L.
- Woltjer, Randall L.
- Yamada, Masahito
- Nelson, Peter T.
- Venue
- Acta Neuropathologica
- Published
- 2014-10-28
- Volume
- 128
- Issue
- 6
- Pages
- 755-766
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC4257842
- OpenAlex
- W1971032265
- Cited by
- 1,467
- References
- 160
- Citations by year
- 2026: 85 · 2025: 126 · 2024: 154 · 2023: 123 · 2022: 154 · 2021: 142 · 2020: 143 · 2019: 131 · 2018: 107 · 2017: 119 · 2016: 105 · 2015: 68 · 2014: 9
- FWCI
- 66.10
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Alzheimer's Association (P30 AG013854, P30AG010124, P01 AG003991, P50 AG025688, P50 AG005681, NIRG-11-204450, P50 AG005136, P50 AG005146)
- BrightFocus Foundation (U01 AG006786, P50 AG016574, P50 AG005136)
- Mayo Foundation for Medical Education and Research (AG016574)
- Alzheimer Forschung Initiative (#13803)
- Alzheimer's Society (AS-PG-2013-011)
- National Institute for Health and Care Research
- Bundesministerium für Bildung und Forschung
- National Institutes of Health (AG028 383, 5r01ag038651-10, AG016574, AG010124, AG005138, AG005133, AG005131, AG008051, AG005681, AG019610, AG003991, AG013854, AG025688, AG003949, AG005136, AG011378)
- Medical Research Council (G0400074, U01 AG006786)
- Japan Society for the Promotion of Science (26430060)
- National Institute on Aging (AG008051, R01‐AG038651, R01AG037212, P30AG028383, P01AG007232, P30AG012300, R37AG018440, P50AG005133, AG184440, U01AG016976, P50AG005131, P50AG005138, U01AG006786, P01AG003949, P30AG010124, AG005131, R01AG011378, P30AG008051, P50AG008702, P50AG005681, P30AG036453, P30AG019610, P50AG005146, P01AG003991, P30AG013846, P50AG005136, P30AG013854, P50AG025688, R01AG041851, P01AG002219, P01AG019724, P50AG016574)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- primary age-related tauopathy, neurofibrillary tangles, tau pathology, Alzheimer's disease, nomenclature, temporal lobe atrophy, tau biomarkers, tau imaging, brain aging, cognitive impairment
- MeSH terms
- Aging, Brain, Diagnosis, Differential, Humans, Terminology as Topic, Tauopathies, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
